Guj. Inject(Ker)

Not Rated
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE659F01014
  • NSEID:
  • BSEID: 524238
INR
83.00
0.9 (1.1%)
BSENSE

Apr 02

BSE+NSE Vol: 59.09 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'17
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 229.04% vs 3,231.11% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 2,296.42% vs 111.90% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 227.70% vs 787.62% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 1,129.03% vs 101.63% in Mar 2024

Compare Profit and Loss Results of Guj. Inject(Ker)
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
19.00
107.00
-88.00
-82.24%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
19.00
107.00
-88.00
-82.24%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
-6.00
6.00
100.00%
Raw Materials Consumed
17.00
74.00
-57.00
-77.03%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
7.00
-7.00
-100.00%
Operating Expenses
0.00
9.00
-9.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
1.00
-1.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
17.00
89.00
-72.00
-80.90%
Operating Profit (PBDIT) excl Other Income
1.00
17.00
-16.00
-94.12%
Other Income
0.00
3.00
-3.00
-100.00%
Operating Profit (PBDIT)
1.00
20.00
-19.00
-95.00%
Interest
0.00
0.00
0.00
0%
Profit before Depriciation and Tax
1.00
20.00
-19.00
-95.00%
Depreciation
0.00
2.00
-2.00
-100.00%
Profit Before Taxation & Exceptional Items
1.00
18.00
-17.00
-94.44%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
1.00
18.00
-17.00
-94.44%
Provision for Tax
0.00
4.00
-4.00
-100.00%
Profit After Tax
1.00
13.00
-12.00
-92.31%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
54.00
-54.00
-100.00%
Profit Available for appropriations
1.00
68.00
-67.00
-98.53%
Appropriations
1.00
68.00
-67.00
-98.53%
Equity Dividend (%)
0%
8%
-8.00
Earnings Per Share
1.13
10.47
-9.34
-89.21%
Profit And Loss - Net Sales
Net Sales 19.05 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 229.04% vs 3,231.11% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1.08 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 2,296.42% vs 111.90% in Mar 2024

Profit And Loss - Interest
Interest 0.00 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 227.70% vs 787.62% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 1.02 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 1,129.03% vs 101.63% in Mar 2024